Kimberly Schluns

Company: Kite: A Gilead Company

Job title: Senior Director Research

Seminars:

Pharma Leaders Fireside Chat: A View of the Innate Immune System as an ‘Off-the-Shelf’ Approach to Cell Therapy 9:45 am

Highlighting the synergies between autologous and allogeneic cell therapies to create a common chassis for development which can ‘plug and play’ with big pharma infrastructure Sharing thoughts on how the intrinsic service component in the commercialization of autologous and allogeneic therapies requires similar patient preparation, additional treatment, follow up, and specialized workforce and how these…Read more

day: Day Two